Efficacy of second-generation-antipsychotics in the treatment of negative symptoms of schizophrenia: A meta-analysis of randomized clinical trials | Revista de Psiquiatría y Salud Mental (English Edition)

Statistics

Original article

Efficacy of second-generation-antipsychotics in the treatment of negative symptoms of schizophrenia: A meta-analysis of randomized clinical trials

Eficacia de los antipsicóticos de segunda generación en el tratamiento de los síntomas negativos de esquizofrenia: un metaanálisis de ensayos clínicos aleatorizados

Josep Darbàa,

Corresponding author

darba@ub.edu

Corresponding author.

, Agnès Minovesb, Emilio Rojoc, Francesca Jimenezc, Javier Rejasd

a Departamento de economía, Universidad de Barcelona, Barcelona, Spain

b BCN Health Economics and Outcomes Research, Barcelona, Spain

c Departamento de Psquiatría, Hospital General de Granollers Benito Menni CASM, Granollers, Barcelona, Spain

d Unidad Médica, Health Outcomes Research Department, Pfizer España, Alcobendas, Madrid, Spain

Read

6082

Times
was read the article

1292

Total PDF

4790

Total HTML

Share statistics

Article information

ISSN: 21735050
Original language: English

DOI:10.1016/j.rpsmen.2011.02.001

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 April	19	7	26
2024 March	64	7	71
2024 February	26	6	32
2024 January	33	10	43
2023 December	27	8	35
2023 November	16	20	36
2023 October	37	17	54
2023 September	19	10	29
2023 August	24	11	35
2023 July	9	14	23
2023 June	21	10	31
2023 May	29	10	39
2023 April	27	23	50
2023 March	34	12	46
2023 February	10	18	28
2023 January	19	9	28
2022 December	18	1	19
2022 November	32	11	43
2022 October	28	11	39
2022 September	36	14	50
2022 August	42	18	60
2022 July	33	9	42
2022 June	33	12	45
2022 May	47	11	58
2022 April	48	10	58
2022 March	69	10	79
2022 February	34	13	47
2022 January	63	12	75
2021 December	75	19	94
2021 November	54	14	68
2021 October	92	23	115
2021 September	46	11	57
2021 August	56	18	74
2021 July	49	13	62
2021 June	61	17	78
2021 May	52	13	65
2021 April	201	48	249
2021 March	132	24	156
2021 February	90	12	102
2021 January	84	18	102
2020 December	83	16	99
2020 November	87	15	102
2020 October	55	9	64
2020 September	55	12	67
2020 August	53	13	66
2020 July	44	16	60
2020 June	55	30	85
2020 May	55	12	67
2020 April	51	15	66
2020 March	64	7	71
2020 February	40	7	47
2020 January	50	18	68
2019 December	73	13	86
2019 November	28	12	40
2019 October	43	8	51
2019 September	38	8	46
2019 August	28	8	36
2019 July	39	4	43
2019 June	32	27	59
2019 May	89	23	112
2019 April	51	4	55
2019 March	30	14	44
2019 February	45	3	48
2019 January	53	11	64
2018 December	48	9	57
2018 November	56	14	70
2018 October	44	7	51
2018 September	81	12	93
2018 August	35	0	35
2018 July	10	2	12
2018 June	12	5	17
2018 May	9	3	12
2018 April	10	8	18
2018 March	10	5	15
2018 February	8	3	11
2018 January	14	1	15
2017 December	13	2	15
2017 November	5	2	7
2017 October	18	3	21
2017 September	9	13	22
2017 August	21	1	22
2017 July	27	3	30
2017 June	25	18	43
2017 May	25	6	31
2017 April	18	5	23
2017 March	19	9	28
2017 February	14	4	18
2017 January	11	2	13
2016 December	11	9	20
2016 November	15	10	25
2016 October	33	7	40
2016 September	47	6	53
2016 August	10	3	13
2016 July	18	2	20
2016 June	24	8	32
2016 May	24	13	37
2016 April	25	14	39
2016 March	34	9	43
2016 February	25	9	34
2016 January	22	9	31
2015 December	23	8	31
2015 November	16	9	25
2015 October	28	5	33
2015 September	21	4	25
2015 August	26	4	30
2015 July	11	6	17
2015 June	14	2	16
2015 May	13	1	14
2015 April	24	10	34
2015 March	28	9	37
2015 February	32	9	41
2015 January	36	8	44
2014 December	46	11	57
2014 November	25	6	31
2014 October	35	6	41
2014 September	18	6	24
2014 August	41	5	46
2014 July	14	1	15
2014 June	21	4	25
2014 May	23	5	28
2014 April	10	2	12
2014 March	26	5	31
2014 February	19	5	24
2014 January	22	7	29
2013 December	31	12	43
2013 November	35	17	52
2013 October	46	10	56
2013 September	37	6	43
2013 August	67	8	75
2013 July	42	6	48

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter